Shaping the future of probiotics: From the latest evidence to the new horizon for L. reuteri Protectis® (DSM 17938)
As the global leader in probiotics for infant colic, BioGaia is pleased to invite you to an in-depth scientific symposium exploring the latest clinical evidence and future perspectives on Limosilactobacillus reuteri Protectis® (DSM 17938). This session will highlight robust clinical data supporting the use of L. reuteri Protectis® in the treatment and prevention of infant colic, functional abdominal pain, acute gastroenteritis, and antibiotic-associated side effects. In addition, we will share BioGaia’s vision for the next generation of probiotic solutions, grounded in science and driven by unmet clinical needs. Designed for healthcare professionals, this symposium aims to support evidence-based decision-making in everyday clinical practice.
Speakers:
Prof. Flavia Indrio, University of Salento, Italy
Prof. Ener Cagri Dinleyici, Eskisehir Osmangazi University, Turkey
Dr. Gianfranco Grompone, BioGaia, Sweden
Key highlights:
- Latest clinical evidence on L. reuteri Protectis® across multiple gastrointestinal conditions
- New insights from a unique 10-year follow-up study of patients with a history of infant colic
- Practical guidance on managing antibiotic-associated side effects, including which patient populations benefit most from probiotic supplementation
- Future directions in probiotic research and innovation, from infant gut health to broader applications
Welcome to our probiotic world on www.biogaia.com
